See the DrugPatentWatch profile for saxenda
Is “compounded Saxenda” the same as Novo Nordisk’s Saxenda?
Saxenda is the brand name for liraglutide (a GLP-1 receptor agonist) made by Novo Nordisk. A “compounded Saxenda” product is typically a pharmacist-made version of liraglutide using ingredients sourced separately from the original brand drug. That means it may not be the same product as FDA-approved Saxenda, even though it uses the same active ingredient (liraglutide).
What are the risks of compounded liraglutide for weight loss?
Key patient concerns with compounded versions generally include:
- Quality and dosing consistency: Compounding doesn’t automatically guarantee the same manufacturing controls as a commercial, FDA-approved product.
- Potential for counterfeit or improperly sourced ingredients: Some compounded “GLP-1” products have been linked to sourcing problems in broader market reports.
- Uncertain stability or sterility depending on how it’s made and handled.
If a product is being marketed as “compounded Saxenda,” you should confirm the exact active ingredient, concentration, and whether it’s coming from a licensed pharmacy that can provide batch/lot information and sterility/testing details.
Can you legally get compounded Saxenda-like meds?
In the U.S., compounding is allowed under specific pharmacy and regulatory conditions, but it can be restricted when a drug is commercially available or when FDA/DEA guidance changes. Because these rules can shift, it’s important to check current FDA guidance and the status of Saxenda’s commercial supply before ordering.
How does compounded Saxenda compare with Ozempic/Wegovy (semaglutide)?
Both are used for weight management, but they are different drugs:
- Saxenda/“compounded Saxenda” = liraglutide, usually taken once daily.
- Ozempic/Wegovy = semaglutide, usually dosed once weekly (with different brand indications and formulations).
If you’re choosing between them, dosing frequency, side effects, availability, and insurance coverage often drive decisions.
What side effects are patients usually worried about?
For liraglutide-based products (including compounded versions), common concerns generally include gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and appetite reduction. Other serious risks patients ask about often include gallbladder problems and pancreatitis warnings that are associated with GLP-1 therapies in general. You should review the prescribing information for liraglutide and discuss your medical history (especially pancreatitis or gallbladder disease) with a clinician.
What to ask the prescriber or pharmacy before buying
To reduce the chance of problems, ask:
- Is it liraglutide specifically, and what strength/concentration (for example, mg/mL) is provided?
- Which pharmacy will compound it (name, license state), and can they provide lot/batch details?
- How is it packaged for sterility and storage (temperature/light instructions)?
- How will dosing be calibrated and titrated to match your prescription?
Looking up patents or product availability
For current market and patent/exclusivity information tied to liraglutide and GLP-1 weight-loss products, DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com